Behzad Masouleh-Kharabi

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

XBP1 promotes NRASG12D pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS.

XBP1 promotes NRASG12D pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS.

Journal: Journal of cellular and molecular medicine

Published: April 13, 2023

Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia.

Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia.

Journal: Cancer cell

Published: January 15, 2020

Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.

Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.

Journal: Carcinogenesis

Published: November 29, 2019

Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia.

Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia.

Journal: Oncotarget

Published: October 07, 2017

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.

Journal: Journal of hematology & oncology

Published: July 08, 2016

Targeting the angio-proteostasis network: Combining the forces against cancer.

Targeting the angio-proteostasis network: Combining the forces against cancer.

Journal: Pharmacology & therapeutics

Published: May 02, 2016

Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph(+) leukemia.

Deregulated expression of the HSP40 family members Auxilin-1 and -2 is indicative of proteostasis imbalance and predicts patient outcome in Ph(+) leukemia.

Journal: Experimental hematology & oncology

Published: November 10, 2015

Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.

Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.

Journal: Oncotarget

Published: July 13, 2015

Drugging the unfolded protein response in acute leukemias.

Drugging the unfolded protein response in acute leukemias.

Journal: Journal of hematology & oncology

Published: May 26, 2015

Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.

Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.

Journal: PloS one

Published: November 03, 2014

Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.

Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 14, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026